Gland Pharma Limited (NSE:GLAND)
India flag India · Delayed Price · Currency is INR
1,648.20
+14.60 (0.89%)
Jun 6, 2025, 12:30 PM IST

Gland Pharma Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2017 - 2020
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2017 - 2020
Revenue
56,16556,64736,24644,00734,629
Upgrade
Revenue Growth (YoY)
-0.85%56.28%-17.64%27.08%31.51%
Upgrade
Cost of Revenue
22,89525,53918,59522,49416,097
Upgrade
Gross Profit
33,27031,10817,65121,51318,532
Upgrade
Selling, General & Admin
14,01612,6684,0473,3973,122
Upgrade
Other Operating Expenses
6,5654,8953,2713,0092,385
Upgrade
Operating Expenses
24,35921,2238,8077,5136,498
Upgrade
Operating Income
8,9119,8858,84414,00012,034
Upgrade
Interest Expense
-420-217.9-62.87-34.02-29.11
Upgrade
Interest & Investment Income
-1,5061,7941,386859.49
Upgrade
Currency Exchange Gain (Loss)
-106.05571.45792.05405.26
Upgrade
Other Non Operating Income (Expenses)
2,1369.1-1.07-2.8577.77
Upgrade
EBT Excluding Unusual Items
10,62711,28811,14616,14213,348
Upgrade
Gain (Loss) on Sale of Investments
-3.4828.4844.89-
Upgrade
Gain (Loss) on Sale of Assets
-2.49-0.81-1.780.24
Upgrade
Asset Writedown
---63.32--
Upgrade
Other Unusual Items
---564.61--
Upgrade
Pretax Income
10,62711,32510,54616,18613,348
Upgrade
Income Tax Expense
3,6413,6012,7354,0693,378
Upgrade
Net Income
6,9857,7257,81012,1179,970
Upgrade
Net Income to Common
6,9857,7257,81012,1179,970
Upgrade
Net Income Growth
-9.57%-1.10%-35.54%21.54%29.00%
Upgrade
Shares Outstanding (Basic)
165165165164158
Upgrade
Shares Outstanding (Diluted)
165165165165158
Upgrade
Shares Change (YoY)
0.01%0.03%0.09%3.96%2.15%
Upgrade
EPS (Basic)
42.4046.9047.4473.8163.07
Upgrade
EPS (Diluted)
42.4046.8947.4373.6462.99
Upgrade
EPS Growth
-9.58%-1.14%-35.59%16.91%26.29%
Upgrade
Free Cash Flow
5,3026,0691,4302,7943,762
Upgrade
Free Cash Flow Per Share
32.1836.848.6916.9823.77
Upgrade
Dividend Per Share
18.00020.000---
Upgrade
Dividend Growth
-10.00%----
Upgrade
Gross Margin
59.24%54.92%48.70%48.88%53.52%
Upgrade
Operating Margin
15.87%17.45%24.40%31.81%34.75%
Upgrade
Profit Margin
12.44%13.64%21.55%27.53%28.79%
Upgrade
Free Cash Flow Margin
9.44%10.71%3.95%6.35%10.86%
Upgrade
EBITDA
12,68913,13810,31015,10213,020
Upgrade
EBITDA Margin
22.59%23.19%28.44%34.32%37.60%
Upgrade
D&A For EBITDA
3,7793,2531,4661,101985.75
Upgrade
EBIT
8,9119,8858,84414,00012,034
Upgrade
EBIT Margin
15.87%17.45%24.40%31.81%34.75%
Upgrade
Effective Tax Rate
34.27%31.79%25.94%25.14%25.31%
Upgrade
Revenue as Reported
58,30158,35038,65146,24635,977
Upgrade
Updated Feb 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.